Evidence map›Paper›PMID 36802023›Full record

ArticleHeart and vessels2023

Clinical application of artificial intelligence algorithm for prediction of one-year mortality in heart failure patients.

Hiroyuki Takahama, Kunihiro Nishimura, Budrul Ahsan, Yasuhiro Hamatani, Yuichi Makino, Shoko Nakagawa, Yuki Irie, Kenji Moriuchi, Masashi Amano, Atsushi Okada and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hiroyuki TakahamaDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan. hiroytakahama@gmail.com.
Kunihiro NishimuraDepartment of Preventive Medicine and Epidemiology, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Budrul AhsanPhilips Japan, Minato-Ku, Tokyo, 108-8507, Japan.
Yasuhiro HamataniDepartment of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, 612-8555, Japan.
Yuichi MakinoPhilips Japan, Minato-Ku, Tokyo, 108-8507, Japan.
Shoko NakagawaDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Yuki IrieDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Kenji MoriuchiDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Masashi AmanoDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Atsushi OkadaDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Takeshi KitaiDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Makoto AmakiDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Hideaki KanzakiDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Teruo NoguchiDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Kengo KusanoDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Masaharu AkaoDepartment of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, 612-8555, Japan.
Satoshi YasudaDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.
Chisato IzumiDepartment of Cardiovascular Medicine, National Cerebral Cardiovascular Center, Suita, 564-8565, Japan.

Funding

Japan Agency for Medical Research and Development 20ek0210128h0002
6 · The paper itself

Abstract

Risk prediction for heart failure (HF) using machine learning methods (MLM) has not yet been established at practical application levels in clinical settings. This study aimed to create a new risk prediction model for HF with a minimum number of predictor variables using MLM. We used two datasets of hospitalized HF patients: retrospective data for creating the model and prospectively registered data for model validation. Critical clinical events (CCEs) were defined as death or LV assist device implantation within 1 year from the discharge date. We randomly divided the retrospective data into training and testing datasets and created a risk prediction model based on the training dataset (MLM-risk model). The prediction model was validated using both the testing dataset and the prospectively registered data. Finally, we compared predictive power with published conventional risk models. In the patients with HF (n = 987), CCEs occurred in 142 patients. In the testing dataset, the substantial predictive power of the MLM-risk model was obtained (AUC = 0.87). We generated the model using 15 variables. Our MLM-risk model showed superior predictive power in the prospective study compared to conventional risk models such as the Seattle Heart Failure Model (c-statistics: 0.86 vs. 0.68, p < 0.05). Notably, the model with an input variable number (n = 5) has comparable predictive power for CCE with the model (variable number = 15). This study developed and validated a model with minimized variables to predict mortality more accurately in patients with HF, using a MLM, than the existing risk scores.

Indexed as

Artificial IntelligenceHeart FailureAlgorithmsHumansPrognosisProspective StudiesRetrospective StudiesHeart failureMachine learningPrognosisRisk prediction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.